Back

Definition of extremely high cardiovascular risk in patients after acute myocardial infarction - Data from the TERCET Registry.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Clinical risk factors, prevalence and prognosis Scores ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Krzysztof Dyrbus

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

13 More presentations in this session

Presentation thumbnail
Identification of patients at extremely-high cardiovascular risk within a very-high risk population from the TERCET Registry.
Associate Professor K. Dyrbus (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Risk Or Benefit IN Screening for CArdiovascular disease (ROBINSCA): results from screening for a high cardiovascular disease risk by using a risk prediction model or coronary artery calcium scoring
Professor H. de Koning (Rotterdam, NL)
Abstract
Presentation thumbnail
Cystatin C based eGFR estimation compared to crea-based estimation equation for assessing risk of cardiovascular and total mortality in population-based studies and patients with manifest CVD
Professor W. Koenig (Munich, DE)
Abstract
Presentation thumbnail
Influence of TCF21 rs12190287 in the coronary artery disease risk prediction. An association study in a Portuguese population.
Doctor J. Sousa (Funchal, PT)
Abstract Slides
Presentation thumbnail
Comparison of APACHE II, SAPS II and GRACE 2.0 risk scores to estimate early and late mortality in patients with ST-segment elevation acute myocardial infarction.
Doctor R. Arroyo-Espliguero (Guadalajara, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Clinical risk factors, prevalence and prognosis

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Presentation
Cardiovascular prevention in older adults
thumbnail
Congress Presentation
Making personalised prevention everyone's business

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources